European Union parliamentarians have written a letter criticizing Novartis for challenging the Indian Law on Patents, believed by many experts to be in compliance with WTO requirements.
Millions of people around the world today rely on affordable medicines produced in India. Pharmaceutical company Novartis is taking the Indian government to court to force a change in the country’s patent law. If Novartis wins, a major source of affordable medicines for millions of people across the globe could dry up.
Doctors Without Borders (Médecins Sans Frontiers) has developed an on-line petition protesting Novartis’ action. MSF is urging Novartis to DROP THE CASE.